UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

Glucose biosensor based on functionalized ZnO nanowire/graphite films dispersed on a Pt electrode

Nanotechnology, 2016-10, Vol.27 (42), p.425501

2016

Link zum Volltext

Verfügbarkeit prüfen

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

Journal of hepatology, 2017, Vol.66 (1), p.S699-S699

2017

Link zum Volltext

Verfügbarkeit prüfen

833 DOWN-REGULATION OF INTERFERON-STIMULATED GENES AFTER ALISPORIVIR INTERFERON-FREE TREATMENT SUGGESTS A UNIQUE ANTIVIRAL MECHANISM OF ACTION FOR ALISPORIVIR, A CYCLOPHILIN INHIBITOR

Journal of hepatology, 2013-04, Vol.58, p.S342-S342

2013

Link zum Volltext

Verfügbarkeit prüfen

O9 BOTH CYCLOPHILIN INHIBITORS AND DIRECT-ACTING ANTIVIRALS PREVENT PKR ACTIVATION IN HCV-INFECTED CELLS

Journal of hepatology, 2014-04, Vol.60 (1), p.S5-S5

2014

Link zum Volltext

Verfügbarkeit prüfen

Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Second Infection

Journal of hepatology, 2016, Vol.64 (2), p.S137-S137

2016

Link zum Volltext

Verfügbarkeit prüfen

Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages

Journal of Virology, 2001-10, Vol.75 (19), p.9187-9200

2001

Link zum Volltext

Verfügbarkeit prüfen

CRV431 and CMX157: anti-HBV combination effects in vitro between a cyclophilin inhibitor and a nucleotide prodrug

Journal of hepatology, 2017, Vol.66 (1), p.S699-S699

2017

Link zum Volltext

Verfügbarkeit prüfen

P0890 : Novel cyclophilin inhibitor CPI-431-32 shows broad spectrum antiviral activity by blocking replication of HCV, HBV and HIV-1 viruses

Journal of hepatology, 2015-04, Vol.62, p.S677-S677

2015

Link zum Volltext

Verfügbarkeit prüfen

1153 CYCLOPHILIN INHIBITOR ALISPORIVIR (ALV) COMBINATIONS WITH DIRECT ACTING ANTIVIRALS REVEAL STRONG SYNERGISTIC ANTI-HCV EFFECTS

Journal of hepatology, 2013-04, Vol.58, p.S469-S469

2013

Link zum Volltext

Verfügbarkeit prüfen

O024 : Cyclophilin and NS5A inhibitors, but not other anti-HCV agents, preclude HCV-mediated formation of double membrane vesicle viral factories

Journal of hepatology, 2015-04, Vol.62, p.S202-S202

2015

Link zum Volltext

Verfügbarkeit prüfen

P1044 NVP018, A CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HBV INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S423-S423

2014

Link zum Volltext

Verfügbarkeit prüfen

Syndecan Captures, Protects, and Transmits HIV to T Lymphocytes

Immunity (Cambridge, Mass.), 2003, Vol.18 (1), p.27-39

2003

Link zum Volltext

Verfügbarkeit prüfen

P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S325-S325

2014

Link zum Volltext

Verfügbarkeit prüfen

Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion

Journal of Virology, 2004-06, Vol.78 (12), p.6567-6584

2004

Link zum Volltext

Verfügbarkeit prüfen

Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import

Journal of Virology, 1996-02, Vol.70 (2), p.1027-1032

1996

Link zum Volltext

Verfügbarkeit prüfen

841 BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HCV INFECTION

Journal of hepatology, 2012-04, Vol.56, p.S328-S328

2012

Link zum Volltext

Verfügbarkeit prüfen

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

The EMBO journal, 1999-12, Vol.18 (23), p.6771-6785

1999

Link zum Volltext

Verfügbarkeit prüfen

Lipopolysaccharide-Binding Protein as a Major Plasma Protein Responsible for Endotoxemic Shock

Proceedings of the National Academy of Sciences - PNAS, 1993-11, Vol.90 (21), p.9935-9938

1993

Link zum Volltext

Verfügbarkeit prüfen

789 PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRIN

Journal of hepatology, 2011-03, Vol.54, p.S317-S317

2011

Link zum Volltext

Verfügbarkeit prüfen

Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection

Viruses, 2012-11, Vol.4 (11), p.2558-2577

2012

Link zum Volltext

Verfügbarkeit prüfen

Syndecans and HIV-1 pathogenesis

Microbes and Infection, 2004-05, Vol.6 (6), p.617-622

Gallay, Philippe

2004

Link zum Volltext

Verfügbarkeit prüfen

Interferon γ receptor deficient mice are resistant to endotoxic shock

The Journal of experimental medicine, 1994-05, Vol.179 (5), p.1437-1444

1994

Link zum Volltext

Verfügbarkeit prüfen

SAT-181 - The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

Journal of hepatology, 2017, Vol.66 (1), p.S699-S699

2017

Link zum Volltext

Verfügbarkeit prüfen

88 PARTICULAR IN VITRO ANTI-HCV ACTIVITIES AND RESISTANCE PROFILE OF THE CYCLOPHILIN INHIBITOR DEBIO 025

Journal of hepatology, 2009, Vol.50, p.S36-S36

2009

Link zum Volltext

Verfügbarkeit prüfen

SAT-356 - Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Journal of hepatology, 2018-04, Vol.68, p.S768-S768

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(109)
Humans
(102)
Animals
(41)
Male
(38)
Biological And Medical Sciences
(35)
Middle Aged
(32)
Biochemistry & Molecular Biology
(30)
Female
(29)
Life Sciences
(28)
Physical Sciences
(22)
Mice
(21)
Molecular Sequence Data
(21)
Immunology
(20)
Medical Sciences
(20)
Adult
(19)
Aged
(19)
Cell Line
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
Human Immunodeficiency Virus 1
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glucose biosensor based on functionalized ZnO nanowire/graphite films dispersed on a Pt electrode

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

833 DOWN-REGULATION OF INTERFERON-STIMULATED GENES AFTER ALISPORIVIR INTERFERON-FREE TREATMENT SUGGESTS A UNIQUE ANTIVIRAL MECHANISM OF ACTION FOR ALISPORIVIR, A CYCLOPHILIN INHIBITOR

O9 BOTH CYCLOPHILIN INHIBITORS AND DIRECT-ACTING ANTIVIRALS PREVENT PKR ACTIVATION IN HCV-INFECTED CELLS

Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Second Infection

Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages

CRV431 and CMX157: anti-HBV combination effects in vitro between a cyclophilin inhibitor and a nucleotide prodrug

P0890 : Novel cyclophilin inhibitor CPI-431-32 shows broad spectrum antiviral activity by blocking replication of HCV, HBV and HIV-1 viruses

1153 CYCLOPHILIN INHIBITOR ALISPORIVIR (ALV) COMBINATIONS WITH DIRECT ACTING ANTIVIRALS REVEAL STRONG SYNERGISTIC ANTI-HCV EFFECTS

O024 : Cyclophilin and NS5A inhibitors, but not other anti-HCV agents, preclude HCV-mediated formation of double membrane vesicle viral factories

P1044 NVP018, A CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HBV INFECTION

Syndecan Captures, Protects, and Transmits HIV to T Lymphocytes

P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTS

Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion

Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import

841 BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HCV INFECTION

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

Lipopolysaccharide-Binding Protein as a Major Plasma Protein Responsible for Endotoxemic Shock

789 PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRIN

Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection

Syndecans and HIV-1 pathogenesis

Interferon γ receptor deficient mice are resistant to endotoxic shock

SAT-181 - The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

88 PARTICULAR IN VITRO ANTI-HCV ACTIVITIES AND RESISTANCE PROFILE OF THE CYCLOPHILIN INHIBITOR DEBIO 025

SAT-356 - Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Suchergebnisse filtern